People with Hepatitis C Who Inject Drugs - Underserved, Not Undeserving

摘要

To reduce the burden of HCV, it will be important to expand harm reduction for people who inject drugs. One model comes from Australia, where high treatment uptake has reduced the prevalence of active infection in this population.